CF gene carriers may face hidden organ risks

NCT ID NCT05474417

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at whether people who carry one copy of the cystic fibrosis gene (CF carriers) have early signs of kidney or pancreas problems. Researchers will compare 1250 CF carriers and non-carriers using blood tests, urine and stool samples, and surveys. The goal is to see if carriers have higher risks for conditions like diabetes or kidney disease.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If this study finds clear links, it could lead to earlier monitoring or preventive care for CF carriers at risk of kidney or pancreas problems.

What could go wrong

This is an early observational study, not a treatment trial. It may not find strong evidence, and results may not apply to all CF carriers.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PANCREATIC DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

kidney disorder pancreas disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Iowa Hospitals and Clinics

    RECRUITING

    Iowa City, Iowa, 52242, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••